Literature DB >> 27515957

Epidemiology and Natural History of Alcoholic Liver Disease.

Mario Masarone1, Valerio Rosato, Marcello Dallio, Ludovico Abenavoli, Alessandro Federico, Carmela Loguercio, Marcello Persico.   

Abstract

Alcohol represents the oldest substance of abuse known, existed at least as early as the Neolithic period. In the present era, almost half of the world's population consumes alcohol and it represents the third largest risk factor for disease and disability and the most prevalent cause of advanced liver disease worldwide. In fact, when alcohol consumption reaches "unsafe quantities" an Alcoholic Liver Disease (ALD) is very likely. ALD comprises a large spectrum of diseases, ranging from simple steatosis to steatohepatitis with fibrosis and cirrhosis. Alcohol related cirrhosis is responsible of almost 50% of all cirrhosis-related and 1% of all-cause deaths worldwide. Even if ALD and alcoholic cirrhosis represent a large part of liver diseases, to know exactly the global burden of these phenomena is very difficult. This is mostly due to diagnostic and nosological issues, being ALD represented by several types of diseases and the diagnosis very often based on voluntary questionnaires. Also the natural history of ALD is somewhat difficult to predict, since there is not a definite evolution between the various stages of the disease and, indeed, they may coexist in a single subject. In this brief review we will report on the global burden of ALD, the principal factors influencing its prevalence among populations and the different presentations of its natural history.

Entities:  

Mesh:

Year:  2016        PMID: 27515957     DOI: 10.2174/1574887111666160810101202

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  15 in total

1.  Colder Weather and Fewer Sunlight Hours Increase Alcohol Consumption and Alcoholic Cirrhosis Worldwide.

Authors:  Meritxell Ventura-Cots; Ariel E Watts; Monica Cruz-Lemini; Neil D Shah; Nambi Ndugga; Peter McCann; A S Barritt; Anant Jain; Samhita Ravi; Carlos Fernandez-Carrillo; Juan G Abraldes; Jose Altamirano; Ramon Bataller
Journal:  Hepatology       Date:  2019-02-27       Impact factor: 17.425

2.  Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Authors:  Srinivasan Dasarathy; Mack C Mitchell; Bruce Barton; Craig J McClain; Gyongyi Szabo; Laura E Nagy; Svetlana Radaeva; Arthur J McCullough
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

3.  Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice.

Authors:  Noemí Cabré; Yi Duan; Cristina Llorente; Mary Conrad; Patrick Stern; Dennis Yamashita; Bernd Schnabl
Journal:  Cells       Date:  2021-06-14       Impact factor: 7.666

4.  Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis.

Authors:  Ji Hyun Kim; Minjong Lee; Seung Woo Park; Myungho Kang; Minjeong Kim; Sang Hoon Lee; Tae Suk Kim; Jin Myung Park; Dae Hee Choi
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

5.  Thymosin β4 Prevents Oxidative Stress, Inflammation, and Fibrosis in Ethanol- and LPS-Induced Liver Injury in Mice.

Authors:  Ruchi Shah; Karina Reyes-Gordillo; Ying Cheng; Ravi Varatharajalu; Joseph Ibrahim; M Raj Lakshman
Journal:  Oxid Med Cell Longev       Date:  2018-07-11       Impact factor: 6.543

6.  Investigating the effect of Crocus sativus L. petal hydroalcoholic extract on inflammatory and enzymatic indices resulting from alcohol use in kidney and liver of male rats.

Authors:  Monireh Azizi; Naser Abbasi; Mojtaba Mohamadpour; Salar Bakhtiyari; Sirous Asadi; Ehsan Shirzadpour; Ali Aidy; Mahmoud Mohamadpour; Mansour Amraei
Journal:  J Inflamm Res       Date:  2019-10-08

7.  MiR-30e-UCP2 pathway regulates alcoholic hepatitis progress by influencing ATP and hydrogen peroxide expression.

Authors:  Xi Jin; Mo-Sang Yu; Yue Huang; Zun Xiang; Yi-Peng Chen
Journal:  Oncotarget       Date:  2017-07-31

8.  A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption.

Authors:  Rosellina Margherita Mancina; Flaminia Ferri; Alessio Farcomeni; Antonio Molinaro; Angela Maffongelli; Monica Mischitelli; Edoardo Poli; Lucia Parlati; Maria Antonella Burza; Adriano De Santis; Fabio Attilia; Claudia Rotondo; Maria Margherita Rando; Maria Luisa Attilia; Mauro Ceccanti; Stefano Ginanni Corradini
Journal:  Appl Clin Genet       Date:  2019-01-10

9.  Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes.

Authors:  Michael Hugh Miller; Andrew Fraser; Gillian Leggett; Alastair MacGilchrist; George Gibson; James Orr; Ewan H Forrest; Ellie Dow; William Bartlett; Chirstopher Weatherburn; Axel Laurell; Kirsty Grant; Kathryn Scott; Ronald Neville; John F Dillon
Journal:  Frontline Gastroenterol       Date:  2018-02-07

10.  Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease.

Authors:  Liuyi Hao; Qian Sun; Wei Zhong; Wenliang Zhang; Xinguo Sun; Zhanxiang Zhou
Journal:  Redox Biol       Date:  2017-11-11       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.